Picture of Trident Texofab logo

540726 Trident Texofab Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
Consumer CyclicalsSpeculativeMicro CapSucker Stock

Annual cashflow statement for Trident Texofab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line12.727.311.725.812.8
Depreciation
Amortisation
Non-Cash Items31.726.841.421.7-10.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital-45.2-12-42.5-201-115
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities13.958.527.1-137-96.4
Capital Expenditures-41.6-2.17-0.575-40.2
Purchase of Fixed Assets
Other Investing Cash Flow Items-2.245.89-5.1445-17.6
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-43.83.73-5.7145-57.8
Financing Cash Flow Items-21.3-33.9-37.8-43.1-7.64
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities29.9-62-20.5366124
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0430.2290.941274-30.4